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Tumor necrosis ractor a (TNFa) stimulated rapid (seconds) hydrolysis oTsphingomyclin in ML-60 cells, formation of phosphochcline (PCho) and 
a dmunsc in choline. The response to TNFa was concentration dependent with a muximal et&et at 3-10 nM. The monoclonal antibody (mAb), 
htr-9, which behaves as an agonist at the 55 kDa subtype of the TNF receptor, also stimulated sphingomyelin hydrolysis in in!act cells. In contrast, 
the mAb, utr-I, which behaves as an antagonist at the 7.5 kDa receptor subtype, had no et’fixt on sphingomyclin hydrolysis either on its own or 
in the prcscnce oTTNFa. In addition, htr-9 or TbIFa stimulated hydrolysis of sphingomyelin in a mcmbranc fraction of ML-60 cells. These results 
are consistent with H role of sphingomyclin hydrolysis as an early event in the sipnalling mechanism of TNFa, and suggest that this pathway is 
activated through the 55 kDa subtype of the TNF rcccptor. 
Tumor necrosis factor a; Sphingomyclinase 
1. INTRODUCTION 
Several metabolites of sphingolipids are biologically 
active molecules that ai?%ct a variety of cellular re- 
sponses [l] including inhibition of growth factor action 
[2,3], modulation of receptor function [4], and antago- 
nism of phorbol ester-induced responses [5,6]. Many of 
these actions appear to be mediated through inhibition 
of protein kinase C by sphingosine [l], although a cer- 
amide-activated protein kinase has also been identified 
[7]. Recent evidence suggests that sphingomyelin and its 
metabolites may play an important role in signal 
transduction. 
Tumor necrosis factor a (TNFa) is a monocyte/mac- 
rophage-derived cytokine with a wide variety of biolog- 
ical activities. TNFa has a cytotoxic/cytostatic effect on 
many transformed cells [8,9], acts as growth factor for 
fibroblasts and chondrocytes [8, lo], stimulates ecretion 
cf prostaglandin E2 in synovial cells [ 1 l] and activates 
a cyclooxygenase in osteoblasts [12]. The specific bind- 
ing of TNFa to cell surface receptors appears to be the 
first step for mediating these events. A variety of cells 
express specific high-afXnity binding sites for TNFa, 
and two major types of receptor have been identified 
with apparent molecular mass of 75 kDa and 55 kDa 
[13,14]. 
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Recently, TNFa has been shown to activate a neutral 
sphingomyelinase to generate ceramide [15,16] and it 
has been suggested that this has an important role in the 
regulation of many of the above responses. However, it 
is not known which of the two receptor subtypes medi- 
ates activation of sphingomyelinase. The present study 
has sought to address this question using ML-60 cells 
which express similar amounts of the 5S and 75 kDa 
receptors. Monoclonal antibodies (mAbs), utr-1 and 
htr-9, which were raised against he 75 kDa and 55 kDa 
receptors, respectively [l’?], were used to determine 
which receptor mediates the effect of TNFa on sphin- 
gomyelin breakdown. 
2. MATERIALS AND METHODS 
TNFor was l’rom British Bio-technology Limited or was a kind gift 
from Dr. R. Foulkes, Cclltech. [!neflry’I-‘H]Choline (SO Wmmol) was 
from Amersham Corp. Silica Gel 60G plates were purchased from 
Merck. Monoclonal anti-TNFa receptor antibodies. utr-I and htr-9, 
were generously provided by Dr. M. Brockhaus. HL-60 cells were 
generously provided by Dr. C. Madin (Dcpanment of Pathology, 
Oxford University). RPM1 1640 medium was from Gibco. Other rea- 
gents were or the highest grade available. 
2.2. Cell nrhre and bbclhhg 
HL-60 cells were grown in RPM1 1640mediumcontaining 10% fetal 
calf serum at 37°C under 5% CO2 in air. For the Inbelling, cells were 
maintained with [3W]cholinc (0.5 yCiim1) in culture medium for 48 h. 
Following labelling, the cells vxre twice washed with l-lank’s buffered 
saline and then incubated with or without TNFa at 20°C or 37OC for 
the indicated time. For the experiments using mAb W-l. cells were 
incubated with utr-1 ( IOpdml) for 1 hand then incubated wi!h TNFo. 
A! the end oT the incubation, 560 ,ul of chl~.~oro~lmcthanol~water 
(1oi):200:2. v/v) was added and phases eparated by adding 190 pi of 
chlorol’onn and water to give a final ratio of 2:2:1 (chloroform/mcth- 
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anollwatcr). The upper aqueous phase was taken for analysis of the 
water-sotuble choline-containing mc!sbolitcs. An aliquot 01’the lower 
phase was dried down for analysis of lipids. 
Dowex-50.WH’ (500 ,ul) was washed with I M I-ICI followed by 
distilled water until a constant pl-I or approx. 5.5 was obtained. The 
upper aqueous phase was loaded onto each column. The run-through 
and a !5 ml water wash wcrc collected together; this l’ruciion contains 
glycerophasphocholinc (GroPCho) and phosphocholine (PCho). The 
choline Traction was cluted by addition of 6 ml I M HCI [lXj. An 
aliquot (6 ml) of each fraction was cotwed for radioactivity following 
addition of scintillant. 
2.4. A rdv.sis OJ lipid bwokrlu~~~r~ 
The lip’ids were separated using chloro~orm/methanol/~ccto~~c/ace- 
tic acid/water (6:2:8:2: I, v/v) on silicu gel 60 TLC plates. After visual- 
izing with iodine vapor, each spot corresponding to phosphati- 
dylcholine and sphingomyelin. assessed by co-clution with authentic 
phospholipids, was scraped and counted for radioactivity lbllowing 
addition or scintillant. 
2.5. :Mcirlbrme pwptrrtrrhr 0f’ HL-60 wits 
Cells. prclabelled for 48 h with PHIcholine, were suspended in a 
solution of 5 mM MgCI:. 100 mM KCI, 20 mM HEPES (pH 7.4) and 
2 mM glucose. and kwogcnizcd by sonication nt -PC. The resulting 
homogenate was c::ntrirun,ed at 15.000 rpm I’or IO min at 4°C. The 
pellet was resuspc; ted in the same bufrcr ;md incubaicd with or 
without TNFcr (IO nM) or mAb htr-9 (1 OpgIml) for the indicated time 
at 37°C. 
Experiments were pcrformcd in quadruplicatc and on at Ieusl two 
occasions. Results arc shown as means 2 S.E.M. und statistical signil: 
icance was indicated by Student’s r-test with P c 0.05 taken as the level 
of signilicance. 
3. RESULTS 
3.1. EjjCect of TNFcx OH [3Hjc!:oli~lc-l~lhc~llen rwtnbolites 
The enzyme sphingomyelinase acts on sphingomyelin 
to produce ceramide and PCho. Recently, scvcral re- 
ports have suggested that TNFa stimulates sphingomy- 
elin h!*drolysis by activation of neutral sphingomyeli- 
nase [15,16]. In the present study, we have examined the 
effect of TNFa on [“H]PCho release in HL-60 cells pre- 
labelled with [“HIcholine. TNFcl stimulated a rapid in- 
creased release in the fraction containing [31-i]GroPCho 
and [“H]PCho in a concentration-dependent manner; it 
was not possible to separate [3H]GroPCho and 
[3H]PCho on Dowex-SO-WH’ columns. The time- 
course of the stimulation was very rapid at 37OC (not 
shown), and so all experiments using intact cells were 
performed at 20°C where maximal increases were ob- 
tained after S-10 min (Fig. IA). The maximally effective 
concentration of TNFa For release of [3H]GroDCho/ 
[3H]PCho was 3-10 nM (Fig. 1C). In contrast, release 
of [3H]choline was decreased by TNFa in a time- and 
dose-dependent manner in intact HL-60 cells (Fig. 1 B 
acd 9). The time-courses a.n.d copP@ntration curves for .-_*..._.. 
[3H]choline release were similar to those for stimulation 
of [3H]GroPCho/[3H]PCho rormation. 
In parallel with the above observations, TNFa stimu- 
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Fig. I. ETTeci of TNFz on [“Hlcholinc-labcllcd metnbolitcs. (A and Et) 
Time-course. The cells were lab&d with PI-llcholinc (O.S/tCi/ml) for 
45 h and then stimulated with (a) or without (0) IO nM TNFr at 20°C. 
The results are lhe mean + S.E.M. of two cxpcriments, performed in 
quodruplicatc. (C and D) Dose depcndcncc. The cells wcrc Iabellcd 
with [JH]choline as above and stimulated with TKFa for IO min. The 
results arc the mean + S.E.M. from oiic typical experiment, pcrl’ormed 
in quadruplicatc, which is reprcscntative of two other similar studies. 
A and C, GroPCho/PCho fraction; B and D. choline rrscticn. 
lated a concentration- and time-dependent decrease in 
[3H]sphingomyelin and [-7H]phosphatidylcholine in in- 
tact cells. A maximal effect was at 10 nM TNFa and is 
shown in Table I along with changes in choline and 
GroPCho/PCho. 
Table I 
ElTect ofmAb ulr-1 and htr-9 on [‘HIcholine-lobcllcd mctabolites and 
VHlcholinc-labelled linids 
GroPCho+PCho Cho Sphingomyc- Phosphatidyl- 
lin choline 
TNF 118.5 !: 0.6* 79.3 2 3.0* 84.0 c 1.0* 90.3 z? 2.1* 
utr-I 103.6 ? I .2 94.6 -I- I.8 95.6 1- 1.2 99.4 & 1.3 
utr-l+TNF 1202 P 0.6* 71.8 Z? 3.7” 81.5 P 0.2” 91.0 P 2.3” 
htr-9 119.2 * 1.5” 77.8 I- 2.2* 77.1 ? 2.2’ 89.7 -c 4.P 
The cells were prclabclled with pH]cholinc rot-48 h and then incubated 
with or without mAb utr-1 (lO,~@ml) Tar 1 h followed by stimulation 
with TNFa (IO nM) or htr-9 (lO,ugfml) for IO min at 37OC. Results 
are shown as % control values (-100% and are the mean ?: S.E.M. of 
two experiments. performed in quadruplicate. *P c 0.05 relative to 
control value. 
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3.2. Effect of rnAb UII=l mcl k-9 CM [3H~cltofirrtu-h- 
MEed tnetabolites 
Two major types of receptor for TNF with apparent 
molecular masses of 75 kDa and 5S kDa have been 
identified. To clarify whether one or both types of re- 
ceptor mediate stimulation of sphingomyelinase activ- 
ity, we used two different mAbs, utr-1 and htr-9. The 
mAb utr-1 was raised against the 75 kDa receptor and 
behaves as antagonist o TNFa at this receptor [19,20]. 
The mAb htr-9 was raised against the SS kDa receptor 
and behaves as an agonist [20,21]. 
As shown in Table I, utr-1 had no effect on TNFa- 
induced changes in [3H]choline lipids and water soluble 
metabolites. On the other hand, htr-9 mimicked the 
action of TNFa. htr-9 (10 &ml) stimulated release of 
[3H]GroPCliolrH]PCho, decreased release of [3H]chol- 
ine and induced hydrolysis of sphingomyelin and phos- 
phatidylcholine (Table 1). These results suggest that 
TNFa stimulates the hydrolysis of sphingomyelin and 
phosphatidylcholine through the SS kDa receptor. 
3.3. Effect of TNFa cmf mAb h-9 ott the rnembrune 
fracriori of HL-60 
In order to verify whether the changes observed in 
intact cells are likely to be direct or indirect actions of 
the 55 kDa receptor, we established an assay to study 
sphingomyelin hydrolysis in membranes prepared from 
cells which had bl:en prelabellcd with [3H]choline for 48 
11. TNFa stimulated release of [3H]GroPCho/[3H]PCho 
in a time-dependent manner similar to that seen in intact 
cells but, in contrast, had no effect on [3H]choline re- 
lease (data not shown). The effect of TNFa and htr-9 
on sphingomyelin metabolism in this cell-free system 
was also assessed. As shown in Fig. 2, both TNFa and 
htr-9 stimulated sphingomyelin hydrolysis with similar 
kinetics; the response was very rapid and was almost 
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Fig. 2. Stimulation of sphingomyelin hydrolysis by TNFa and mAb 
htr-9. Cells were prelnbclled with [‘H]choline and the mrmbrznu fmc- 
lion prepared as described in Matcrinis und Methods. ivicmbrtinca 
were rcsuspendcd and stimulated with TNFa (IO nM) or mAb htr-9 
(IO &/ml) ror various periods. Data are the mean f S.E.M. of two 
experiments, performed in quadruplicate. A, TNFa; B, mAb htr-9. 
complete within 1 min of addition of TNFa or htr-9. No 
effect on phosphatidylcholine metabolism was observed 
(data not shown). 
4. DISCUSSION 
In this study, the effect of mAb’s raised against the 
75 kDa and 55 kDa receptors for TNF were examined 
to clarify which receptor mediates the signalling path- 
way for sphingomyelinase activation. The mAb utr-1, 
which binds to the 75 kDa receptor and has been re- 
ported to block the ability of TNFa to interact with this 
receptor, had no effect on sphingomyelin hydrolysis by 
TNFa. In contrast, htr-9, which binds and activates the 
55 kDa receptor, mimicked the ability of TNFa to stim- 
ulate formation of [3H]GroPCho/[3H]PCho and hydrol- 
ysis of sphingomyelin and phosphatidylcholine in intact 
cells and in membranes. These results suggest hat the 
55 kDa receptor activates sphingomyelinase to hy- 
drolyse sphingomyelin, and phospholipases C and/or D 
to hydrolyse phosphatidylcholinc. The observntions 
that both TNFa and htr-9 stimulate sphingomyelinase 
in intact cells and in membranes with rapid kinetics 
suggest hat this is an early and potentially important 
event in the signalling pathway utilized by TNFa. How- 
ever, the absence of phosphatidylcholint hydrolysis in 
membranes uggest hat this is not directly coupled to 
receptor activation and may be mediated subsequent to 
hydrolysis of sphingomyelin, for example by a cer- 
amide-activated kinase [15,22]. 
In contrast o the increase in formation of [3H]PCho/ 
[3H]CiroPCho, TNFa and htr-9 stimulated a decrease in 
[3H]clloline in intact HL-60 cells, although this cff‘ect 
was not observed in membranes. The absence of a 
change in [3M]choline levels in the membrane studies 
suggests that this event is secondary to hydrolysis of 
sphingomyelin and phosphatidylcholine, and may re- 
flect re-incorporation of choline into lipids following 
their hydrolysis. 
Activation of a neutral sphingomyelinase by TNFa 
will generate formation of ceramide. Increasing 
amounts of this lipid are associated with monocytic 
differentiation [IS] and phosphorylation of the epidcr- 
ma! growth factor receptor [22] in HL-60 cells, possibly 
through a ceramide-activated protein kinase [ 15,221. It
is possible that generation of ceramide by the S5 kDa 
receptor underlies many, if not all of the actions of this 
TNF receptor subtype. 
nck,lo~~tl~~~~ftr~~~s: We nre grateful to Dr. R. Foulkcs, Celltech, 
Slough, for kindly supplying TNFa, and Dr. Brockhaus, Roche. for 
supplying the monoclonal antibodies utr-1 and htr-9. S.P.W. is a 
Royal Society University Research Fellow. This work was supported 
by the ARC. 
REFERENCES 
[I] lltinnun, Y.A. and Bell, R.M. (1989) Science 243. 500-507. 
299 
Volume 314, number 3 FEBS LElTERS December 1992 
[2] Hnnai, N., Nores, G., Torrcs-Mcndez. CR. and Hakomori, S. 
(1337) Biochem. Biophys. Res. Commun. 147, 127-134. 
[3] Hall. F.L., Fcrnyhouph, D., Ishii, D.N. and Vullict, P.R. (1985) 
J. Biol. Chem. 263, 4460-4466, 
[4] Faucher, M., Girones, N., Hannun, Y.A., Bell, R.M. and Davis, 
R.J. (1985) J. Biol. Chum. 263, 5319-5327. 
[S] Mcrill, A.H.. Scrcni, A.M., Stevens, V.L., Hannun, Y.A., Bell, 
R.M. and Kinkodc, J.M. (1956) J. Biol. Chcm. 261,12610-12615. 
[G] Grove, D.D. and Mastro, A.M. (1988) Biochem. Biophys. Res. 
Commun. I .5 I, 94-99. 
[7] Baijalieh, S.M., Martin, T.F.J. and Floor, E. (1989) J. Biol. 
Chem. 264, 14354-14360. 
[i3] Sugarman, B.J., Aggarwal, B.B., Hass, P.E., Palladino, M.A. and 
Shcoard. H.M. ll9851 Science 230.943-945. 
[9] Williamson, B.D., &swell, W.A:, Rubim, B.Y., Prendergast, 
J.S. and Old, 1.1. (1983) Proc. Natl. Acad. Sci. USA SO, 5393- 
5401. 
[lo] Ikebe. T., Hirata, M. and Koga, T. (1988) J. Immunol. 140, 
s27-s31. 
[1 I] Dayer. J.M.. Beutler, B. and Ceromi, A. (1955) J. Exp. Med. lG2, 
2163-2168. 
[I?] Yanaga, F., Abe, M.. Kogu, T. and Hirata, M. (1992) J. Biol. 
Chem. 267, 5114-Sl21. 
[13] Loctscher, H., Pan, Y.E.. Lahm, H.W.. Gentz, R., Brockhous, 
M., Tauchi, H. and Lcsslaucr, W. (1990) Cell (ii, 351-359. 
[14] Schall, T., Lewis, M,, Kollcr, K.J., Lee, A., Rice, G.C., Wang, 
G.H.W., Galnnngo, T., Gmngcr, G.A., Leulz, R., Rabb, II., 
Kohr. W.J. and Gocddel, D.V. (1990) Ccl1 61, 361-370. 
[ 151 Drcsslcr, K.A., Mathias, S. and Kolcsnick, R.N. (1992) Science 
255, 1715-1717. 
[16] Kim, M.Y., Linardic, C., Clbcid, L. and Hannun, A.Y. (1991) J. 
Biol. Chcm. 266, 484489. 
[17] Brockhnus, M., Schocnrcld, M.J., Schlueger, E.J., Hunziker, W., 
Lcsslaucr, W&and Loetsher, 1-I. (1990) Proc. Natl. Acad. Sci. USA 
87, 3127-3131. 
[18] Cook, S. and Wakelmnn, M. (1989) Biocbcm. J. 263, 581-587. 
[19] Shalaby, M-H., Sundan, A., Loetscher, H., Brockhaus, M., Lass- 
laucr, W. and Espevik, T. (1990) 1. Exp. Med. 172, 1517-1520. 
[201 Hohmann. H., Brockhaus. M., Baeuerle, P.A., Rcmy, ii., 
Kolbeck, R. and van Loon, A.P.G.M. (1990) J. Biol. Chcm. 265, 
22409-224 17. 
[al] Espcvick, T., Brockhaus, M., Loetscher. H., Nonstad, U. and 
Shulaby, R. (1990) J. Exp. Med. 171,415-426. 
[22] Math&, S., Drcsslcr, K.A. and Kolesnick, R.N. (1991) Proc. 
Nat]. Acdd. Sci. USA 88. 10009-10013. 
